Two more new drugs approved under "1+" mechanism

Two new drugs for hypercalcaemia in patients with parathyroid carcinoma and primary hyperparathyroidism approved under Hong Kong's '1+' mechanism, which simplifies drug registration by requiring approval from one reference place and local clinical data.